Results 11 to 20 of about 21,802 (304)

Effects of model tear proteins and topical ophthalmic formulations on evaporation inhibition and biophysical property of model tear lipid nanofilm in vitro

open access: yesJCIS Open, 2021
Hypothesis: Biophysical property and water evaporation retardation through a lipid nanofilm can be altered by model tear protein and topical ophthalmic formulation.
Meng C. Lin, Tatyana F. Svitova
doaj   +1 more source

A study on the most prevalent bacterial cause of corneal ulcer and their susceptibility to five common types of ophthalmic antibiotics [PDF]

open access: yesTrends in Pharmaceutical Sciences, 2020
Purpose: Proper diagnosis of the corneal ulcer is one the most important efforts in the eyes medical urgencies. The aim of this study was to determine the bacteriological profile and in vitro antibiotic resistance of the bacteria isolated from the eyes of
Nazafarin Hatami-Mazinani   +3 more
doaj   +1 more source

Recalcitrant Pseudomonas Aeruginosa Keratitis with Hyphaema

open access: yesCase Reports in Ophthalmology, 2021
Purpose: To report a case of recalcitrant pseudomonas keratitis with a rare presentation of hyphaema. Observation: A 45-year-old female was noted to have contact lens-related pseudomonas keratitis with hyphaema.
Amy Chan   +3 more
doaj   +1 more source

Central Anticholinergic Syndrome Following Excessive Mydriatic Use in an Eight-Year-Old Patient

open access: yesTrends in Pediatrics, 2021
Cyclopentolate hydrochloride, belonging to a class of drugs known as anticholinergics, is an ophthalmic solution frequently used in ophthalmology clinics because of its cycloplegic and mydriatic effects in both refractions as well as fundus examinations.
Nazan Kaymaz   +4 more
doaj   +1 more source

2% Ganciclovir Eye Drops Control Posner-Schlossman Syndrome Relapses With/Without Cytomegalovirus Intraocular Reactivation

open access: yesFrontiers in Medicine, 2022
BackgroundTo observe and compare the efficacy of 2% ganciclovir eye drops in the treatment of Posner-Schlossman Syndrome relapses with/without cytomegalovirus intraocular reactivation.MethodsA prospective cohort study enrolling 101 patients diagnosed ...
Qilian Sheng   +11 more
doaj   +1 more source

New ophthalmic drug delivery systems [PDF]

open access: yesFarmacia Hospitalaria, 2020
For decades, topical ophthalmic drug administration through the use of eye drops has been the most widely used technique for the treatment of eye diseases.
Ana Castro-Balado   +3 more
doaj   +1 more source

A Review on Conventional and Novel Topical Ocular Drug Delivery System

open access: yesJournal of Pharmacy, 2021
Ocular drug delivery is a very challenging area for ophthalmologists and drug delivery scientists due to the structural and barrier complexity of the eye.
Mohamad Faeznudin Rozi   +1 more
doaj   +1 more source

Evaluation of the sterility condition of commonly used eye drops present in the Egyptian pharmacies. [PDF]

open access: yesJournal of Bioscience and Applied Research, 2016
Fourty samples of commonly used eye drops were collected from The Egyptian Pharmacies and divided into 2 groups: group A (with antimicrobial activity) and group B (without antimicrobial activity), the two groups cultured on blood agar medium and ...
A.A. Abo Elnasr   +4 more
doaj   +1 more source

NIGHTMARES FROM TOPICAL TIMOLOL EYE DROPS: A CASE REPORT

open access: yesKhyber Medical University Journal, 2020
Topical timolol eyedrops are frequently used as medical treatment of glaucoma. They decrease the production of aqueous humor by blocking the beta adrenergic receptors of ciliary body.
Yousaf Jamal Mahsood, Saima Farooq
doaj   +1 more source

Thimerosal: current sources of contact in Brazil [PDF]

open access: yesAnais Brasileiros de Dermatologia, 2014
Thimerosal is an organic mercury derivative found in ophthalmic solutions and certain vaccines in Brazil. Although most studies suggest the prevalence of thimerosal sensitivity to be quite high, this condition does not currently have any clinical ...
Vanessa Barreto Rocha   +1 more
doaj   +1 more source

Home - About - Disclaimer - Privacy